OPEN END TURBO BULL OPTIONSSCHEIN - ELI LILLY & CO | Real-time BOERSE MUENCHEN 20:41:33 25/06/2024 BST | ||
| 40.15 EUR | +2.21% |
|
| Current month | +25.70% | ||
| 1 month | +27.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 40.15 | +2.21% |
| 24/06/24 | 39.28 | +1.47% |
| 21/06/24 | 38.71 | +0.57% |
| 20/06/24 | 38.49 | -2.41% |
| 19/06/24 | 39.44 | +1.02% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 08:41 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HC7998 |
| ISIN | DE000HC79986 |
| Date issued | 08/06/2023 |
| Strike | 471.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.01 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 40.54 € |
|---|---|
| Lowest since issue | 0.6 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
904.6
USD
Average target price
860.5
USD
Spread / Average Target
-4.87%
- Stock Market
- Certificates
- Certificat
